| Abstrakt: |
A recent study conducted by researchers at the National University of Singapore explored the potential neuroprotective effects of ergothioneine (ET) on dopaminergic neurons, which are often affected in Parkinson's disease. The study found that ET had a protective effect on these neurons, reducing oxidative stress and mitochondrial dysfunction. The researchers also discovered that the protective effects of ET were inhibited by a specific inhibitor, suggesting that ET may have an intracellular mechanism of action. These findings suggest that ET could be a potential therapeutic option for Parkinson's disease. [Extracted from the article] |
